Cancer Drugs: AstraZeneca Wins Big (Again!) - Is This Thing On?

AstraZeneca's Enhertu: Makin' Cancer Stall Like My Old Nag!

Alright alright settle down! Donkey's here to tell you about some serious dragon slayin' news – only this time the dragon's CANCER! AstraZeneca and some fancy Japanese folks made a drug called Enhertu and it's makin' breast cancer sit down and shut its yap for over a year! That's longer than I can keep Shrek from grumbling in the morning! They're sayin' it could change the game which is great 'cause let's be honest nobody likes games with cancer involved. One of them fancy execs said that it's gonna give people a 'chance to potentially have a longer progression free survival time.' I don't know what that means but it sounds like good news right? Right!

Pfizer's Pill: Double the Survival Double the Fun! (Maybe?)

Now hold on to your waffles 'cause Pfizer's got a pill called Braftovi and it's makin' colorectal cancer patients live TWICE as long! That's like gettin' two slices of Fiona's swamp pie instead of one! They mixed it with some other potions and BAM! The bad stuff got hammered! Pfizer's big cheese said that about 10% to 15% of folks get this weird mutation thing and their survival rates are uh not great. But Braftovi is gonna change that! They're so proud they're probably gonna throw a parade... through a swamp maybe? Hey I'm game!

Gilead & Merck: Tag Teamin' Breast Cancer Like a Wrestling Match!

Gilead and Merck decided to team up and give breast cancer a wedgie using Trodelvy and Keytruda! Seems like those two drugs went out for pizza and decided to make an aggressive type of breast cancer 35% less aggressive! That's like taking the fire out of a dragon's breath! Some fancy doctor said that it will 'likely become a new front line standard of care.' Which I think means they're gonna use it a lot. Good right? Gotta keep those villains down!

Merck & Daiichi Sankyo: Oh No... Sometimes Things Don't Work Out.

Uh oh here comes a sad trombone. Merck and Daiichi Sankyo tried to make a drug for lung cancer but it didn't quite work out. The thing failed to prolong the lives of lung cancer patients. Even though I joke around I know how much this must hurt especially after all the effort they put in. At least they're learning what works and what doesn't. It's kinda like when I try to make Shrek laugh with a bad joke. Sometimes it works sometimes I get a face full of swamp gas!

Amgen's Imdelltra: Breathin' New Life into Lung Cancer Treatment!

Buckle up buttercups because Amgen's Imdelltra is comin' in HOT! This drug is givin' small cell lung cancer patients a fighting chance. It reduces the risk of death by 40%! That's like cuttin' a dragon's wings by half! Not literally of course. Unless...? Anyway they extended the median overall survival which means folks are livin' longer. All in all this is a great win for all.

Bonus Round: Bristol Myers Squibb and BioNTech: A Team Up of Epic Proportions!

And finally we have Bristol Myers Squibb and BioNTech teamin' up to create a new cancer immunotherapy. They are determined to throw hands at Keytruda and new treatments in development by Summit Therapeutics and Pfizer. What can I say I love a good underdog story. You go Bristol you go.